HITRIplus - Heavy Ion Therapy Research Integration

🚀 Since June 2021, we’ve hosted 23 seminars advancing knowledge in particle therapy. And we’re not stopping here. Although HITRIplus officially ends on March 31, our seminars will continue! 👉 Stay tuned. #ParticleTherapy #Innovation #Research

We are very pleased to invite you to the last HITRIplus Seminar, which will take place on Wednesday, 2 March 2026, from 17:00 to 18:00 CEST. Full details & Zoom link: indico.cern.ch/event/1653476/ We look forward to your participation and a lively discussion

🎅🎄Best wishes for a Merry Christmas and Happy New Year from HITRIplus Community #hitriplus #hadrontherapy #HeavyIontherapy #hightecnologyresearch #particletherapy #heavyions #carbonions #innovation

We are very pleased to invite you to the next HITRIplus Seminar, which will take place on Wednesday, 10 December 2025, from 17:00 to 18:00 CEST. 👉 Full details & Zoom link: indico.cern.ch/event/1617929/ We look forward to your participation and a lively discussion

Great participation for the 20th Seminar of HITRIplus 📸Here some pictures! 👉 Full details: indico.cern.ch/event/1586839/

📌 JOIN THE ECM COURSE: THINK HADROM 2025 – Neuro-oncology
✨ 30 FREE REGISTRATION SLOTS – ONLY UNTIL OCTOBER 1! 🚀 👉 REGISTER NOW: fad.accmed.org/course/info.ph… 👉 DISCOVER THE FULL PROGRAM: fondazionecnao.it/uploads/2025-9…

The next HITRIplus Seminar will take place on Wednesday, 1 October 2025, from 17:00 to 18:00. Speaker: Dr Daria Boscolo (GSI, Darmstadt) Title: Radioactive Ion Beams for Image-Guided Particle Therapy & Biomedical Applications 👉 Full details & Zoom link: lnkd.in/dpPuRcqP

💡HITRIplus at the 6th RICH TNA Webinar that will take place online on 10th April 2025 at 10.00 CET. Dr. Konrad Lehmann (GSI Helmholtz Centre for Heavy Ion Research) will participate as speaker to present the HITRIplus TNA. ➡️ FOR MORE INFORMATION: rich-europe.eu/events/webinar…

2/2 Honored to present SEEIIST's journey at the Hadron Cancer Therapy Workshop 🇲🇪. Special thanks to Sandro Rossi & all experts involved!  Big thanks to the @EU_Commission for funding this project to beat cancer with cutting-edge technologies! #CancerResearch #EU

1/2 @SEEIIST – A flagship for EU Enlargement advancing towards construction!  #HITRIplus project gifted SEEIIST the Design Phase, thanks to 18 leading European research & medical centers, including @CERN, @GSI_Helmoltz, & 4 hadron cancer therapy centers.

Only a few days 📆 left for "HadronTherapy Workshop: from innovation to implementation”, which will take place in Podgorica, Montenegro, from March 24th to 25th as part of the SEEIIST Association’s program. ➡️ FOR MORE INFORMATIONS: indico.cern.ch/event/1488001/

💡 Don't miss the opportunity to participate in the HadronTherapy Workshop "From Innovation to Implementation”, . Sign up now. You have until March 7! ➡️ FOR INFORMATION: hitriplus.eu/events_and_tra…

📸Some pictures from the 19th Seminar of HITRIplus “Hadrontherapy in Caen-Normandy“

💡 The 19th Seminar of HITRIplus "Hadrontherapy in Caen-Normandy" is approaching, set for February 24. ➡️➡️Don't miss out this opportunity: register now and be part of the conversation! indico.cern.ch/event/1512755/

👏👏👏👏 institut-curie.org/news/instituti…

💡 REGISTRATION IS OPEN for “HadronTherapy Workshop: from innovation to implementation”, which will take place in Podgorica, Montenegro, from March 24th to 25th, 2025, as part of the SEEIIST Association’s program. ➡️ FOR INFORMATION: hitriplus.eu/events_and_tra…

CERN's particle accelerator tech is being reimagined to blast cancer in under a second techspot.com/news/106466-ce…

📌 Don't forget the HadronTherapy Workshop: from innovation to implementation, to be held in Podgorica (Science and technology Park of Montenegro) from 📆 March 24 to 25 2025. STAY TUNED‼️

Best wishes for a Merry Christmas and Happy New Year from HITRIplus Community⛄️❄️ #hitriplus #hadrontherapy #HeavyIontherapy #hightecnologyresearch #particletherapy #heavyions #carbonions #innovation

Qualche scatto del Clinical TNA di HITRIplus che si sta svolgendo in CNAO @heavy_ion